menu
    • menu

    Company profile for Immunic Therapeutics

    NEW Drugs in Dev: 5
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunic is a biotechnology company developing a clinical pipeline of orally administered, small-molecule therapies for chronic inflammatory and autoimmune diseases. Immunic is developing orally administered, small molecule programs: The company’s lead development program, vidofludimus calcium (IMU-838), is currently in phase 3 and phase 2 clinical trials for the treatment of relapsing and progressive multiple sclerosis, resp...
    Immunic is a biotechnology company developing a clinical pipeline of orally administered, small-molecule therapies for chronic inflammatory and autoimmune diseases. Immunic is developing orally administered, small molecule programs: The company’s lead development program, vidofludimus calcium (IMU-838), is currently in phase 3 and phase 2 clinical trials for the treatment of relapsing and progressive multiple sclerosis, respectively, and has shown therapeutic activity in phase 2 clinical trials in patients suffering from relapsing-remitting multiple sclerosis and moderate-to-severe ulcerative colitis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immunic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Avenue of the Americas Suite 200 New York, NY 10036
    Telephone
    Telephone
    +1 3322559811
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://imux.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunic-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ImmunicInc/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunic Appoints Michael W. Bonney as Board Chair
    Immunic Appoints Michael W. Bonney as Board Chair

    19 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-appoints-seasoned-biopharmaceutical-executive-michael-w-bonney-as-chair-of-the-board-of-directors-302774994.html

    PR NEWSWIRE
    19 May 2026
    Share Share
    Immunic Reports Q1 2026 Financials And Corporate Update
    Immunic Reports Q1 2026 Financials And Corporate Update

    13 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-inc-reports-first-quarter-2026-financial-results-and-provides-corporate-update-302769899.html

    PR NEWSWIRE
    13 May 2026
    Share Share
    Immunic To Participate In Investor And Medical Conferences In May
    Immunic To Participate In Investor And Medical Conferences In May

    30 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-to-participate-in-investor-and-medical-conferences-in-may-302758603.html

    PR NEWSWIRE
    30 Apr 2026
    Share Share
    Immunic Names Panzara as Chief Medical Officer
    Immunic Names Panzara as Chief Medical Officer

    28 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-md-mph-as-chief-medical-officer-302755439.html

    PR NEWSWIRE
    28 Apr 2026
    Share Share
    Immunic, Inc. Announces 1-For-10 Reverse Stock Split
    Immunic, Inc. Announces 1-For-10 Reverse Stock Split

    23 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-inc-announces-1-for-10-reverse-stock-split-302747385.html

    PR NEWSWIRE
    23 Apr 2026
    Share Share
    Immunic To Attend April Medical Conferences
    Immunic To Attend April Medical Conferences

    09 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-to-participate-in-scientific-and-medical-conferences-in-april-302736609.html

    PR NEWSWIRE
    09 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search